Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Daniel B. Soland files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Mark C. Schneyer - $1.13M in ACAD purchases and sales in the last 12 months
- James M. Daly - $671K in ACAD purchases and sales in the last 12 months
- James Kihara - $603K in ACAD purchases and sales in the last 12 months
- Elizabeth H.Z. Thompson - $506K in ACAD purchases and sales in the last 12 months
- Adams Catherine Owen - $250K in ACAD purchases and sales in the last 12 months
- Jennifer J. Rhodes - $245K in ACAD purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Daniel B. Soland?
Daniel B. Soland is a corporate insider of ACADIA PHARMACEUTICALS INC (ACAD). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Daniel B. Soland last file a Form 4?
The only primary Form 4 on record is dated 29 May 2025.
